“DETECTABLE IN-BLOOD BRCA1 METHYLATION AS A BIOMARKER OF BREAST CANCER PREDISPOSITION”, IJITSS, vol. 1, no. 1(49), Jan. 2026, doi: 10.31435/ijitss.1(49).2026.4552.